BIOBEAT
Biobeat develops a wearable device for continuous, noninvasive, accurate, medical-grade monitoring of vital signs that include blood pressure, oxygen saturation, respiratory rate, heart rate, consciousness, cardiac output, stroke volume, body temperature, steps, and sweat. Its wearable device automatically uploads the recorded data to a smartphone-based application and to the cloud, where the application can monitor it remotely. Caretakers can intervene if needed, and users can receive alerts di... rectly from the app. This provides caretakers with an important tool to assist in disease management and optimize clinical outcomes. The Biobeat system also facilitates remote monitoring of patients with a variety of medical issues. Ultimately, this solution allows patients to be treated in their homes. It can monitor stationary patients as well as those who perform outdoor activities. In 2018, Biobeat received FDA 510K clearance (K181006) for its monitoring system and partnered with DRIVe, a division of the Biomedical Advanced Research and Development Authority, to develop a wearable monitoring device that diagnoses the flu and infections before any symptoms appear. In August 2019, Biobeat received 510K FDA clearance for its patch and watch.
BIOBEAT
Industry:
Biotechnology Elder Care Health Care Internet Of Things Medical Device Wearables
Founded:
2016-01-01
Address:
Petah Tiqva, HaMerkaz, Israel
Country:
Israel
Website Url:
http://www.bio-beat.com
Total Employee:
11+
Status:
Active
Contact:
+ 972 3 9333022
Email Addresses:
[email protected]
Total Funding:
8 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default LetsEncrypt Apple Mobile Web Clips Icon Content Delivery Network Domain Not Resolving Mobile Non Scaleable Content Amazon
Current Employees Featured
Founder
Investors List
Menomadin Foundation
Menomadin Foundation investment in Series A - Biobeat
Newest Events participated
Official Site Inspections
http://www.bio-beat.com Semrush global rank: 1.74 M Semrush visits lastest month: 13.61 K
- Host name: 147.62.236.23.bc.googleusercontent.com
- IP address: 23.236.62.147
- Location: Mountain View United States
- Latitude: 37.4043
- Longitude: -122.0748
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 94043
More informations about "Biobeat"
Biobeat - Crunchbase Company Profile & Funding
Contact Email [email protected] Phone Number +972 3 9333022 Biobeat develops a wearable device for continuous, noninvasive, accurate, medical-grade monitoring of vital signs that โฆSee details»
Biobeat Company Profile | Management and Employees List
Biobeat Profile and History. Biobeat is a med-tech company with unique health-AI capabilities in the patient monitoring space. The company's remote patient monitoring (RPM) health-AI โฆSee details»
Biobeat Company Profile 2024: Valuation, Funding
Information on valuation, funding, cap tables, investors, and executives for Biobeat. Use the PitchBook Platform to explore the full profile.See details»
Biobeat Company Profile - Office Locations, Competitors ... - Craft
Nov 8, 2021 See insights on Biobeat including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.See details»
Biobeat - Foreign Startup | Startup Nation Finder
Dec 31, 2023 Biobeat is a med-tech company providing FDA-cleared, cuffless blood pressure monitoring. The small, non-invasive sensor is placed onto the patientโs chest for 24 hours, and the measurements are taken through our โฆSee details»
FDA Clears the Biobeat Remote Patient Monitoring Device and โฆ
PETAH TIKVA, Israel, March 28, 2022 /PRNewswire/ -- Biobeat, a global leader in wearable remote patient monitoring solutions for the healthcare co...See details»
Arik Ben Ishay, CEO of Biobeat - Interview Series
Dec 22, 2020 Arik Ben Ishay, CEO and co-founder of Biobeat, is a volunteer paramedic with MDA, Israelโs National Emergency Pre-Hospital Medical and Blood Services Organization, served as a paramedic for one of the Israeli โฆSee details»
BioBeat Stock Price, Funding, Valuation, Revenue & Financial โฆ
Acorai. Acorai focuses on developing medical devices within the healthcare sector, specifically targeting heart failure management. The company offers a non-invasive heart monitor that โฆSee details»
BIOBEAT: First-ever: FDA Clears Biobeat's โฆ
Aug 26, 2019 Biobeat, a bio-medical technology company developing advanced sensing and remote monitoring solutions for patients, announced today that the U.S. Food and Drug Administration (FDA) has granted a 510K clearance for โฆSee details»
Biobeat Remote Patient Monitoring Devices and โฆ
Jan 9, 2023 Biobeat is a med-tech company with unique health-AI capabilities in the patient monitoring space. The company's remote patient monitoring (RPM) health-AI platform includes a disposable short-term chest-monitor and a long โฆSee details»
Biobeat gets FDA nod to measure more vital signs on its RPM โฆ
Mar 29, 2022 Biobeat has received 510(k) approval from the US Food and Drug Administration (FDA) for its wearable remote patient monitoring (RPM) platform to measure additional vital โฆSee details»
Clinical Trials and Research - Biobeat
Biobeatโs solution for clinical trials and research enhances clinical data access using our remote monitoring devices alongside our AI tools that are based on experience with more than 10,000 โฆSee details»
FDA Clears the Biobeat Remote Patient Monitoring Device and โฆ
PETAH TIKVA, Israel, March 28, 2022 /PRNewswire/ -- Biobeat, a global leader in wearable remote patient monitoring solutions for the healthcare continuum, announced today that its โฆSee details»
Biobeat widens lead over Apple, Fitbit with FDA nod to add more โฆ
Mar 28, 2022 Though major tech developers like Apple and Google-owned Fitbit have taken center stage in the race to infuse wearable technology with as many health-tracking โฆSee details»
Biobeat's AI-Powered Remote Patient Monitoring ... - Markets Insider
May 4, 2021 Remote Patient Monitoring Platform Provides Continuous Vital Sign Measurement and Patient Deterioration Identification Capabilities In Hospital and Home SettingsSee details»
FDA Clears the Biobeat Remote Patient Monitoring Device and โฆ
Mar 27, 2022 First In The World! We are excited to receive another FDA clearance, making the Biobeat device and platform the only remote patient monitoring solution that provides cuffless โฆSee details»
In Hospital Monitoring - Biobeat
Solution overview: Biobeat's in-hospital monitoring solution is based on our disposable chest-monitor and enables accurate monitoring of all patients through one cloud-based platform, โฆSee details»
Biobeat Launches Wearable Continuous Ambulatory Blood โฆ
PETAH TIKVA, Israel, May 26, 2021 /PRNewswire/ -- Biobeat, a global leader in wearable remote patient monitoring solutions for the healthcare continuum, announced today the launch of its โฆSee details»
Biobeat Expands Access of Wearable Cuffless 24 Hour Ambulatory โฆ
PETAH TIKVA, Israel, Oct. 19, 2021 /PRNewswire/ -- Biobeat, a global leader in wearable remote patient monitoring solutions for the healthcare continuum, announced today that it has made โฆSee details»